A multicentre study of the evidence for customized margins in photon breast boost radiotherapy. by Harris, EJ et al.
BJR doi: 10.1259/bjr.20150603
Received:
22 July 2015
Revised:
10 November 2015
Accepted:
19 November 2015
© 2015 The Authors. Published by the British Institute of Radiology under the terms
of the Creative Commons Attribution 4.0 Unported License http://creativecommons.
org/licenses/by/4.0/, which permits unrestricted use, distribution and reproduction in
any medium, provided the original author and source are credited.
Cite this article as:
Harris EJ, Mukesh MB, Donovan EM, Kirby AM, Haviland JS, Jena R, et al; . A multicentre study of the evidence for customized margins in
photon breast boost radiotherapy. Br J Radiol 2016; 89: 20150603.
FULL PAPER
Amulticentre study of the evidence for customizedmargins
in photon breast boost radiotherapy
1EMMA J HARRIS, PhD, 2,3MUKESH B MUKESH, MD, FRCR, 4ELLEN M DONOVAN, PhD, 4ANNA M KIRBY, MD, FRCR,
5,6JOANNE S HAVILAND, MSc, 2RAJ JENA, PhD, FRCR, 1JOHN YARNOLD, FRCR, 7ANGELA BAKER, MSc, 2JUNE DEAN, BSc,
4SALLY EAGLE, BSc, 7HELEN MAYLES, PhD, 5CLAIRE GRIFFIN, MSc, 8ROSALIND PERRY, PGDip,
9ANDREW POYNTER, BSc, FIPEM, 2CHARLOTTE E COLES, PhD, FRCR, 10PHILIP M EVANS, PhD and On behalf of the
IMPORT high trialists
1Radiotherapy and Imaging, Institute of Cancer Research Sutton, UK
2Oncology Centre, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK
3Oncology Centre, Colchester Hospital University NHS Trust, Colchester, UK
4The Breast Unit, Royal Marsden Hospital NHS Foundation Trust, Sutton, UK
5ICR-CTSU, Institute of Cancer Research, Sutton, UK
6Macmillan Survivorship Research Group, Faculty of Health Sciences, University of Southampton, UK
7Department of Physics, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK
8Department of Radiotherapy, Ipswich Hospital NHS Trust, Ipswich, UK
9Radiotherapy Department, Peterborough City Hospital, UK
10CVSSP, University of Surrey, Guildford, UK
Address correspondence to: Emma Harris
E-mail: emma.harris@icr.ac.uk
Objective: To determine if subsets of patients may
benefit from smaller or larger margins when using laser
setup and bony anatomy verification of breast tumour
bed (TB) boost radiotherapy (RT).
Methods: Verification imaging data acquired using
cone-beam CT, megavoltage CT or two-dimensional
kilovoltage imaging on 218 patients were used (1574
images). TB setup errors for laser-only setup (dlaser) and
for bony anatomy verification (dbone) were determined
using clips implanted into the TB as a gold standard for
the TB position. Cases were grouped by centre-, patient-
and treatment-related factors, including breast volume,
TB position, seroma visibility and surgical technique.
Systematic (S) and random (s) TB setup errors were
compared between groups, and TB planning target
volume margins (MTB) were calculated.
Results: For the study population, Slaser was between
2.8 and 3.4mm, and Sbone was between 2.2 and 2.6mm,
respectively. Females with larger breasts (p50.03), easily
visible seroma (p#0.02) and open surgical technique
(p#0.04) had larger Slaser. Sbone was larger for females
with larger breasts (p50.02) and lateral tumours
(p50.04). Females with medial tumours (p,0.01) had
smaller Sbone.
Conclusion: If clips are not used, margins should be 8 and
10mm for bony anatomy verification and laser setup,
respectively. Individualization of TB margins may be con-
sidered based on breast volume, TB and seroma visibility.
Advances in knowledge: Setup accuracy using lasers and
bony anatomy is influenced by patient and treatment
factors. Some patients may benefit from clip-based image
guidance more than others.
INTRODUCTION
Cancer recurrence within the breast is most likely to
occur in the region of the tumour bed (TB). A radiotherapy
(RT) boost to the TB reduces the risk of local relapse and
is recommended for patients at higher risk of recurrence.1
It has also been shown that an RT boost to the TB can
increase the risk of normal tissue toxicity such as ﬁbrosis.2
The risk of ﬁbrosis may increase as the volume of the TB
planning target volume (PTV) increases.3 A larger PTV
may also affect the dose delivered to other normal tissues.
For example, recent work by Darby et al4 suggests there is
no safe dose threshold for cardiac tissues. A suitable boost
PTV margin will encompass the TB throughout the
course of RT and treat minimal non-target tissue to re-
duce the risk of both local relapse and normal tissue
toxicity.
Titanium surgical clips and gold ﬁducial markers have
been shown to be effective imaging surrogates for the
TB.5,6 Here, we refer to both surgical clips and gold
markers as clips. TB clips can inﬂuence placement of
ﬁelds7 and assist in the planning of partial breast and
boost RT.8 Increasingly, photon boosts are used as it is easier to
visualize and optimize planned dose distribution compared
with electron boosts. Combining photon boost and TB clips
enables the use of image-guided RT to verify the position of the
TB. It has been shown that using clips, PTV margins of 5mm
can be used safely to deliver both sequential and synchronous
photon boost RTwith steep dose gradients.9 Clip-based image-
guided RT and 5-mm PTV margins are strongly recommended
by the Intensity Modulated Partial Organ Radiotherapy
(IMPORT) trials group.7–9 However, this is not routine practice
worldwide. A common alternative imaging veriﬁcation method is
X-ray (megavoltage or kilovoltage) imaging of bony anatomy,
and if imaging is not available, a laser-based setup using skin
marks is used. Neither X-ray imaging using bony anatomy
nor laser setup can directly verify the position of the TB in the
absence of implanted markers. This is because the breast can
move independently from the chest wall and the TB may change
in shape and size within the breast, e.g. reabsorption of the TB
seroma ﬂuid.
This study aimed to investigate the consequences of using laser-
only veriﬁcation or bony anatomy veriﬁcation on setup accuracy
in TB boost RT. The study used imaging data from ﬁve UK
IMPORT High trial centres.10 These data were from kilovoltage
cone-beam CT (kVCBCT), megavoltage CT (MVCT) and two-
dimensional kilovoltage (2DkV) planar imaging. Analysis in-
volved matching of clips and bony anatomy to reference images.
The study investigated:
1. TB setup errors for (i) bony anatomy veriﬁcation and (ii)
laser-based setup, using TB clip position as the gold standard
TB position.
2. Inﬂuence of patient-, surgery- and RT-related factors on TB
setup errors, including breast volume, position of the TB, the
presence of seroma, surgical technique, the presence of
posterior fascia clip(s), number of clips, time from surgery to
CT, time from CT to RT and trial arm.
3. Time required to match veriﬁcation images with reference
images to bony anatomy and clips.
METHODS AND MATERIALS
National Health Service Research Ethics Committee (REC)
approval for this study was granted as a substantial amendment
to IMPORT High National Health Service REC approval (Cam-
bridgeshire 4 REC on 22/10/2010 (REF: 08/H0305/13)). All
IMPORT High patients consented for their imaging and plan-
ning data to be used for research.
Patients
218 patients, from 5 cancer centres were included (Centres
A–E). All patients received whole breast RT and TB boost as part
of the UK IMPORT High trial (testing sequential vs synchronous
integrated boost).10,11 Patients consented for their data to be
used for research purposes. All patients had surgical clips
implanted into the TB and were treated using clip-based veri-
ﬁcation (using online or ofﬂine veriﬁcation protocols) for their
TB boost.5 This was a retrospective study, which had no impact
on the patients’ treatment. Patients were selected sequentially, by
the date of their treatment.
Patient setup and imaging
All patients were positioned using laser alignment of tattoos.
Two or three tattoos were marked: one anterior, medial at the
midline and one or two lateral. All centres used an immobili-
zation wedge beneath the knees, centre B used ankle immobi-
lization also, and all patients were treated in supine position
using a breast board with either one or two arms abducted.
All patients had CT imaging for treatment planning. At
treatment, patients were initially positioned using lasers (laser
setup) and then imaged using either kVCBCT (Synergy,
Elekta Ltd, UK) (Centre A, n5 79), MVCT (TomoTherapy,
Accuray Inc., Sunnyvale, CA) (Centre B, n5 39) or orthog-
onal (0° and 90°) 2DkV ﬁelds (OBI Varian Oncology Systems
Inc., Paolo Alto, CA) (Centres C, D and E, n5 40, 30 and 30,
respectively). For Centre A, using an ofﬂine protocol, the
mean number of images acquired was 5.2 for control arm
patients (sequential boost) and 7 for test arm patients (syn-
chronous boost). For centres an online protocol (B–E), the
number of images acquired was 8 and 15 for control and test
arm patients, respectively.
Imaging data analysis
All image data analysis for this study was performed ofﬂine. For
each image, matching of the reference and veriﬁcation images
was performed using1 clip match and2 bony anatomy match
(Figure 1). Clip match gave the translational shift between clip
position after laser set-up and the reference clip position (on
planning CT). Bony anatomy match gave the translational shift
between bony anatomy position after laser set-up and the ref-
erence bony anatomy position (on planning CT). Shifts in the
left–right (LR), superior–inferior (SI) and anteroposterior (AP)
directions were recorded. The time to perform the clip and bone
matches was recorded. One or two observers performed the
matching of all images at each centre (Centre A, EH; Centre B,
MM; Centre C, AB; Centre D, EH; and Centre E, EH and RP)
and were blinded to image matches recorded during treatment.
Interobserver error analysis was carried out by three observers
who matched three images from three patients selected at ran-
dom, at Centres A (CBCT), B (MVCT) and C (2DkV). Mean
setup error across observers was calculated per image, and the
difference between each observer’s measurement and mean was
determined. Interobserver error was the standard deviation in
differences, calculated for each imaging technique. For intra-
observer analysis, three observers, EH (CBCT and 2DkV), MM
(MVCT) and AB (2DkV), were asked to match three images on
three different days. Mean setup errors across repeat measure-
ments were calculated per image, and the difference between
each observer’s measurement and mean was determined. The
intraobserver error was the standard deviation in differences
calculated for each observer.
Tumour bed setup errors and margins
TB setup error after laser-based setup was the distance between
the position of the TB clips after laser setup and the reference
TB clip position, i.e. TB clip position was used as the gold
standard for TB position. This was referred to as dlaser and was
the TB setup error if no imaging veriﬁcation was used. TB
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setup errors after bony anatomy veriﬁcation were the distance
between TB position after bony anatomy match and the ref-
erence TB position. This was referred to as dbone and was the
TB setup error if imaging veriﬁcation of bony anatomy was
performed and the patient was shifted to ensure bony anatomy
position was correct. An individual patient’s systematic and
random setup errors, for laser and bony anatomy veriﬁcation,
were calculated using the mean and root mean square of dlaser
and dbone using all images available for the patient. The group
systematic TB setup error for laser setup (Slaser) and bony anat-
omy veriﬁcation (Sbone) and the group random TB setup error
for laser setup (slaser) and bony anatomy veriﬁcation (sbone) were
calculated following refs.9 and.12 For bony anatomy veriﬁcation,
TB setup errors are for an online imaging protocol with no action
level. A TB PTV margin (MTB) formulation for breast boost was
used to estimate the tumour bed margin required for laser setup
and bony anatomy veriﬁcation:13
MTB5 2:5+1 0:3s; (1)
To estimate MTB, setup errors were added in quadrature with the
errors associated with using clips as a surrogate for the TB. TB
surrogate systematic and random errors were 1.2 and 0.9mm,
respectively, based on the ﬁndings of.14
Patient- and treatment-related factors
Patient and treatment factors were collected (Table 1). Patient-
related factors included breast volume (whole-breast PTV con-
strained by skin surface and chest wall) and TB position
(Figure 2). Factors relating to patients’ surgery included apposed
(closed) or unapposed (open) cavity, the latter allowing seroma
ﬂuid to accumulate. Seroma visibility was scored by a single
radiation oncologist (MM), who rated seroma as not visible/
subtle or easily visible15 and determined the number of clips
placed at the posterior fascia and in the excision cavity. RT-related
Figure 1. Example images used for setup error analysis. (a) and (b) show sagittal planning CT images (pink) overlaid with sagittal
cone-beam CT images (green). Figures (c) and (d) show planning axial CT images in grey and axial megavoltage CT in yellow.
Figures (e) and (f) show two-dimensional kilovoltage projection images overlaid on digitally reconstructed images from the
planning CT; planning CT clips positions are marked with yellow crosses. Images in the left-hand column (a, c and e) show bone-
matched images and images in the right hand column (b, d and f) show clip-matched images. For colour image see online.
Full paper: Customized breast boost radiotherapy margins BJR
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factors were days between CT and RT (tCT–RT), days between
surgery and RT (tSurgery–RT) and trial arm.
Statistical methods
Cases were grouped according to patient- and treatment-related
factors. Cases were dichotomized above and below the median
value for breast volume, number of clips, time from surgery to
planning CT (tS–CT) and time from planning CT to RT (tCT–RT).
Additionally, cases were grouped according to TB position,
seroma visibility, surgical closing technique, the presence of clip
in the posterior fascia and trial arm (synchronous or sequen-
tial boost).
All data were tested for normality using Shapiro–Wilks test, and
results indicated that the majority of the data (90%) were non-
normal. Differences between median dlaser and dbone and dif-
ferences between centres were tested using Wilcoxon and
Kruskal–Wallis tests.
Differences in systematic and random TB setup errors between
(i) techniques (laser setup and bony anatomy veriﬁcation),
(ii) centres and (iii) between groups by patient- or treatment-
related factors were tested. Non-parametric Levene’s test was
used to test for differences in the variance of patient systematic
dlaser and dbone. Kruskal–Wallis test was used to test for differ-
ences in the patients’ random dlaser and dbone. Relationships
between variables shown to give signiﬁcantly different system-
atic errors were investigated using Kruskal–Wallis tests. For fac-
tors with two or more groups, sensitivity analysis was performed
by removing one group at a time and repeating tests using
Holms–Bonferroni correction.
RESULTS
Tumour bed setup errors and margins
Unless otherwise stated, all differences were statistically sig-
niﬁcant, and p-values were ,0.001. The number of patients
and images (fractions) analysed for each centre is given in
Table 2. At Centres A and C, all available images were analysed.
At Centres B, D and E, ﬁve, six and six images per patient were
analysed, respectively. Using only ﬁve images was validated by
a comparison of setup data calculated using 15 images vs 5
images for 28 cases. The mean differences in patients’ mean
and standard deviation of setup errors were 0.006 and
0.013 cm, respectively.
Table 1. Patient and treatment factors
Variables
Number of patients with
data in each group
Total number of
patients with data
Median
value (range)
Patient related:
TB axial position (1/2/3/4) (Figure 1.) 30/96/33/59 218
TB SI position (1/2/3) (Figure 1.) 107/90/21 218
Breast volume (above median/below
median) (cm3)
109/109 218 855 (118–2847)
Surgery related:
Seroma visibility (not visible/easily visible) 158/60 218
Surgical closing technique (closed/open) 113/88 201
Number of clips (above median/below median) 109/109 218 6 (4–14)
Clip in posterior fascia (no/yes) 40/178 218
Radiotherapy related:
Time from surgery to CT (days) 101/102 203 133 (32–481)
Time from CT to RT (days) 102/102 204 20 (3–112)
Trial arm [synchronous (test) or
sequential (control)]
72/146 218
RT, radiotherapy; SI, superior–inferior; TB, tumour bed.
Factors have been categorized according to the information they provide.
Median values and ranges are given for continuous variables.
Figure 2. Schematic diagram showing (a) tumour bed (TB)
position viewed on axial CT slice (1 5medial, 2 5chest wall,
3 5anterior and 4 5lateral) and (b) TB superior–inferior position
viewed on sagittal CT slice (1 5 superior, 2 5 middle and
3 5 inferior).
BJR Harris et al
4 of 9 birpublications.org/bjr Br J Radiol;89:20150603
Intraobserver and interobeserver errors were ,1.4mm for all
imaging modalities. There were no signiﬁcant differences in
observer errors between centres (p5 0.34).
Mean (and 95th percentile) absolute values of dlaser and dbone in
the LR, SI and AP directions are given in Table 2. Over all data,
the mean absolute TB setup error for laser-only setup (dlaser)
and for bony anatomy veriﬁcation (dbone) was ,4 and 3mm in
all directions, respectively. Compared with other centres, mean
dlaser and dbone was signiﬁcantly greater and smaller in all
directions for Centre B (MVCT), respectively. Variation between
centres was greatest in the AP direction. dlaser was statistically
signiﬁcantly greater than dbone in all directions across all centres.
Group systematic (S) and random (s) errors for laser setup and
bone veriﬁcation are given in Table 3. Combining the data from
all centres, Slaser was statistically signiﬁcantly greater than Sbone
in the LR and AP directions but not in the SI direction. Centre B
had smaller Sbone compared with other centres in all directions
and had larger Slaser compared with other centres (p5 0.002).
TB margins for laser setup and bony anatomy veriﬁcation are
given in Table 4.
Association of tumour bed setup errors with patient-
and treatment-related factors
Breast volume, seroma visibility and surgical technique were
found to inﬂuence Slaser (Table 5). Females with larger breasts
(p50.03), easily visible seroma (p-values# 0.02) and who have
received an open surgical closing technique (p-values# 0.04)
had larger Slaser. Breast volume and TB axial position were
found to inﬂuence Sbone (Table 5). Sbone was larger in one
direction for females with larger breasts (p5 0.015) and lateral
tumours (p5 0.04). Females with medial tumours (p5 0.002)
had smaller Sbone. No statistically signiﬁcant associations be-
tween breast volume, TB position, seroma visibility and surgical
closing technique were found.
Random TB setup errors (Table 6) for laser setup (slaser) were
inﬂuenced by breast volume and seroma visibility. Random TB
setup errors for bony anatomy veriﬁcation (sbone) were inﬂu-
enced by TB axial position, breast volume, surgical closing
technique and trial arm (p-values, 0.05).
The difference in combined timing data for matching using
bony anatomy and clips was not statistically signiﬁcant
(p5 0.29). Within individual centres, the time to match images
using bony anatomy (tbone) and clips (tclip) was different except
for in Centre B. There was a statistically signiﬁcant difference
between matching times between all centres except between
Centres D and E. The time required to analyse MVCT images
was greatest.
DISCUSSION
Tumour bed setup errors and margins
TB setup errors using laser setup were slightly larger than those
of bony anatomy veriﬁcation. This study found the mean three-
dimensional dbone (magnitude of the 3D vector for dbone) to be
4.1mm, smaller than that reported in previous studies on small
cohorts (n, 12) with median of 5.4mm18 and mean of 6mm.19T
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Although our results differ from these smaller studies, they are
in keeping with a larger study by Penninkhof et al (n5 80)16
who found Slaser to be 2.6mm (LR), 2.5mm (SI) and 3.4mm
(AP). Penninkhof et al also evaluated the systematic error after
an ofﬂine 2D portal imaging protocol and found systematic
error Sbone of 2.3mm (LR), 2.4mm (SI) and 2.8mm (AP),
which were similar to values of Sbone in the present study.
Variation in tumour bed setup errors between
centres
There were small but statistically signiﬁcant differences in ab-
solute TB setup errors between centres. These were greatest in
the AP direction. At Centre E, the cause was unknown and was
investigated. At Centre B, a non-zero mean systematic mean
error was due to couch sag, discussed in a previous report,20
which introduced the large mean absolute errors (Table 2) and
overall systematic error (Table 3). Both Centres B and E used an
online imaging protocol, which will remove these errors. Best
practice is to eliminate such errors.
Centre B had smaller dbone in all directions. The poorer im-
aging resolution of MVCT and higher X-ray energy made
MVCT matching less straightforward20 and is evident from
longer matching times (Table 2). Poorer visibility of landmarks,
making it harder to match images, may have accounted for the
smaller difference between clips and bony anatomy at Centre B.
Poorer image quality was proposed as a contributing factor to
smaller estimated setup errors using megavoltage compared with
kilovoltage imaging.21 Exclusion of centre B in the overall calcu-
lation of 3D TB setup error for bony anatomy veriﬁcation gave 3D
dbone5 4.8mm, which is closer to values reported in
18 and.19
Influence of patient- and treatment-related factors
on setup errors
Breast volume, seroma visibility and surgical closing technique
affected TB systematic errors for laser setup. Changes in clip
positions (relative to each other) over a course of RT may affect
the accuracy of laser setup to skin marks. Penninkhof16 found
patients with open surgical technique had greater clip motion
compared with those with closed surgical technique, although
the difference in motion was not signiﬁcant (p5 0.22). Pre-
viously, we observed greater changes in clip positions in patients
with large seroma.22
Axial TB position and breast volume affected TB systematic
errors for bone veriﬁcation. These factors and trial arm (syn-
chronous or sequential boost) affected TB random errors.
Hasan et al23 reported correlation between mean 3D TB setup
errors for bony anatomy veriﬁcation (3D dbone) and breast
volume. Our study showed that TBs in Regions 1 (medial) and
4 (lateral) had smaller and larger TB systematic errors in the AP
and LR directions, respectively. It is likely that there was less
movement of medial breast tissue compared with bony anatomy
and signiﬁcant movement of lateral breast tissue, which may
help explain these results. Hasan et al23 reported correlation of
3D dbone with TB distance from the chest wall determined using
planning CT (n5 27). Similarly, Topolnjak et al24 showed that
the distance of the TB from the chest wall was correlated with
the difference between TB setup errors for the chest wall and
breast surface (r5 0.5, p5 0.034).
Time to perform clip and bony anatomy match
The time for matching using clips (tclips) or bony anatomy
(tbone) was signiﬁcantly different at individual centres. For
Centre A (kVCBCT), tbone was less than tclip because bone
matching was automated using chamfer matching (XVI synergy,
Elekta Ltd, Crawley, UK). For centres C, D and E, tbone was
greater than tclip, indicating that 2DkV imaging bony anatomy
matching was less time efﬁcient than using clips. The differences
Table 3. Systematic and random tumour bed (TB) setup errors for laser-only setup and bone verification for each centre and all
centres combined
Centre
Laser setup random
error slaser (mm)
Laser setup systematic
error (Slaser) (mm)
Bone verification
random error
(sbone) (mm)
Bone verification
systematic error
(Sbone) (mm)
LR SI AP LR SI AP LR SI AP LR SI AP
ALL 3.3 2.9 3.3 3.1 2.8 3.4 1.9 2.8 2.3 2.2 2.6 2.2
A (kVCBCT) 2.7 3.0 2.7 2.8 2.4 2.9 1.6 2.9 2.4 2.3 2.2 2.2
B (MVCT) 4.4 3.2 4.7 3.3 2.7 4.4 1.7 2.2 2.5 1.1 1.6 1.4
C (2DkV) 3.2 2.5 2.5 3.0 2.8 2.7 2.2 3.4 2.3 2.5 2.6 2.4
D (2DkV) 2.6 3.0 3.1 2.5 2.8 2.7 2.0 2.6 2.1 2.1 2.9 2.4
E (2DkV) 4.1 2.6 3.5 3.7 2.7 3.6 2.1 2.7 2.1 2.2 2.9 2.1
AP, anteroposterior; ; kVCBCT, kilovoltage cone-beam CT; LR, left–right; MVCT, megavoltage CT; SI, superior–inferior; 2DkV, two-dimensional
kilovoltage.
Values given in bold indicate significant differences (p#0.05) between centres.
Table 4. Tumour bed planning target volume margins (MTB) or
all centres combined
Laser setup MTB (mm) Bone verification MTB (mm)
LR SI AP LR SI AP
9.0 9.0 10.0 7.0 8.0 7.0
AP, anteroposterior; LR, left–right; SI, superior–inferior.
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in time to match bony anatomy between centres using 2DkV
imaging are unknown but may be a result of different observers.
Clinical relevance
The IMPORT High trial protocol recommends clip veriﬁcation
and a 5-mm PTV isotropic margin for boost RT. We calculated
that a 9–10mm and 7–8mm margin is required for laser setup
and bony anatomy veriﬁcation, respectively (Table 4). Larger
margins are likely to increase PTV volume and the dose to
normal breast tissue and the heart.25 Where possible, clip veri-
ﬁcation should be used; if this is not available, bony anatomy
veriﬁcation (CBCT or 2DkV) offers modest reduction in PTV
volume compared with laser-only setup. For bony anatomy
veriﬁcation, we assumed an online protocol with no action level;
if an action level or ofﬂine protocol is used, these margins may
be greater. In addition, clips may reduce setup error for the
whole breast RT (SWB); using bony anatomy as a surrogate for
the whole breast, we found that SWB was signiﬁcantly smaller in
all directions after clip setup compared with after laser setup
(data not given). This implied that in a synchronous boost
setting, clip setup would allow a whole-breast PTV margin re-
duction. Further work is required to quantify this reduction.
Table 5. Systematic tumour bed (TB) setup errors for laser setup (Slaser) and for bone verification (Sbone) for groups determined
using patient- and treatment-related factors
Laser Factor Group 1 Slaser (mm) Group 2 Slaser (mm) p-value Direction
Breast volume ,855 cm3 2.5 $855 cm3 4.2 0.03 SI
Seroma visibility Not visible/subtle 2.8 Easily visible 3.5 0.02 LR
Not visible/subtle 2.6 Easily visible 3.2 0.002 SI
Not visible/subtle 3.1 Easily visible 4.1 0.005 AP
Surgical closing technique Closed 2.7 Open 3.3 0.02 LR
Closed 2.5 Open 3.2 0.04 SI
Bones Factor Group 1 Sbone (mm) Group 2 Sbone (mm) p-value Direction
TB axial position 1, 2 and 3 2.1 4 2.7 0.04 LR
TB axial position 1 1.6 2, 3 and 4 2.3 0.002 AP
Breast volume ,855 cm 1.9 $855cm3 2.7 0.015 SI
AP, anteroposterior; LR, left–right; SI, superior–inferior; TB, tumour bed.
P-values for univariate non-parametric Levene’s test are given. Data given only for factors that gave a significant difference in systematic bony
anatomy verification error between patient groups (p,0.05).
Table 6. Random tumour bed (TB) setup errors for laser setup (slaser) and for bone verification (sbone) for groups determined using
patient- and treatment-related factors
Laser Factor Group 1 slaser (mm) Group 2 slaser (mm) p-value Direction
TB PTV volume ,39.5 cm3 2.6 $39.5 cm3 2.8 0.041 LR
TB PTV volume ,39.5 cm3 2.6 $39.5 cm3 3.1 0.023 AP
Breast volume ,855 cm 2.4 $855 cm3 3.1 0.006 LR
Breast volume ,855 cm 2.4 $855 cm3 2.8 0.02 SI
Seroma visibility Not visible/subtle 2.6 Easily visible 3.1 0.034 AP
Bones Factor Group 1 sbone (mm) Group 2 sbone (mm) p-value Direction
TB axial position 1 2.0 2, 3and 4 1.6 0.025 LR
TB axial position 1 1.5 2, 3 and 4 2.1 0.004 AP
TB SI position 1 1.8 3 1.1 0.006 LR
Breast volume ,855 cm 2.2 $855 cm3 2.6 0.007 LR
Breast volume ,855 cm 1.7 $855 cm3 2.3 0.002 SI
Trial arm Synchronous 2.1 Sequential 1.8 0.01 AP
Surgical technique Closed 1.4 Open 1.9 ,0.001 LR
Surgical technique Closed 2.3 Open 2.6 0.009 SI
AP, anteroposterior; LR, left–right; PTV, planning target volume; SI, superior–inferior, TB, tumour bed.
P-values for univariate Kruskal–Wallis test are given.
Data given only for factors that gave a significant difference in systematic bony anatomy verification error between patient groups (p,0.05).
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Association of patient- and treatment-related factors with TB
setup errors suggest that individualization of treatment margins
could be considered. Non-isotropic margins are not currently
employed in breast RT. This work suggests that patient-speciﬁc
margins and non-isotropic margins should be considered. It also
suggests that some patients beneﬁt more from clip-based veri-
ﬁcation compared with bony anatomy veriﬁcation than others.
If appropriate margins are applied, patients with large breasts or
laterally located TBs will beneﬁt from a greater reduction in the
breast tissue irradiated if clips are used. Conversely, patients with
smaller breasts or medially located tumours may beneﬁt less
from clip-based veriﬁcation.
Study limitations
This study assumed no signiﬁcant difference among patient
populations from the ﬁve different centres. Comparison of
patient- and treatment-related factors between centres found
small differences between centres in the number of clips and
seroma visibility only. Centres B and E had signiﬁcantly greater
seroma visibility [patients with easily visible seroma: A, 22%;
B, 38%; C, 17%; D, 13%; and E; 53% (p5 0.024)] and median
number of clips [A, C and D, 6; B, 7; and E, 5 (p5 0.012)].
A large source of systematic error in breast boost RT, delin-
eation error, has not been included in this analysis. Observer
variation has been calculated in terms of the variation in TB
volume (for example17); however, it is unclear how this will
affect TB margins and there remains an opportunity for this to
be explored. This work identiﬁes the requirement for larger TB
PTV margins if laser setup or bony anatomy veriﬁcation is
used, which results in a modest increase in the volume of normal
breast tissue receiving the boost dose.24 The clinical effect of
an increase in volume of normal tissue irradiated is not yet
fully understood.26
CONCLUSION
Patients with larger breasts, easily visible seroma and open
surgical closing technique have greater setup errors when laser-
only setup is used. Patients with larger breasts and laterally lo-
cated tumours have greater setup errors when bony anatomy
veriﬁcation is used. If margins derived from patient setup errors
are applied, these groups of patients will beneﬁt from a greater
reduction in breast tissue irradiated if clips are used. Clip veri-
ﬁcation enables smaller margins than bony anatomy veriﬁcation
and should be used where possible. If clips are not available,
bony anatomy veriﬁcation may give modest improvements in
TB setup errors compared with laser setup, and in-
dividualization of TB margins may be considered based on
breast volume, the position of the TB and seroma visibility.
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